Shots:

• The DCGI has granted a EUA for ZyCoV-D which is the world's first plasmid DNA vaccine for COVID-19. The company is planning to seek approval for the two-dose regimen of the vaccine
• ZyCoV-D will become India’s first vaccine for adolescents aged 12-18 yrs. The vaccine is safe and well-tolerated
• ZyCoV-D is a three-dose- needle-free- intradermal vaccine that leads to a reduction in any side effects & administered using PharmaJet for painless delivery. The company plans to manufacture 10-12 crore doses annually

  | Ref: PRNewswire | Image: Zydus